| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.08 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.09 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |